A major federal survey finds adolescent marijuana use has dropped sharply since 2011, challenging a core argument made by prohibition advocates worldwide.
Mexico's amparo system turned a Supreme Court ruling into a personal right. The story of how ordinary people claimed it has lessons far beyond Latin America.
A complex debt-for-equity deal transfers commercialisation rights to a financially fragile drinks company — with implications for patients across the EU.
As more Maltese households explore home cultivation, understanding light distribution and plant training could make the difference between a modest harvest and a meaningful one.
As clinical research on cannabinoids and chronic pain matures, Malta's regulated framework puts it in a unique position to translate science into policy.
As the UK's medical cannabis sector faces mounting scrutiny over weak clinical evidence, the lesson for Malta's emerging framework is clear: data collection must begin now.
A major federal survey finds adolescent marijuana use has dropped sharply since 2011, challenging a core argument made by prohibition advocates worldwide.
A major federal survey finds adolescent marijuana use has dropped sharply since 2011, challenging a core argument made by prohibition advocates worldwide.
A major federal survey finds adolescent marijuana use has dropped sharply since 2011, challenging a core argument made by prohibition advocates worldwide.
Mexico's amparo system turned a Supreme Court ruling into a personal right. The story of how ordinary people claimed it has lessons far beyond Latin America.
A complex debt-for-equity deal transfers commercialisation rights to a financially fragile drinks company — with implications for patients across the EU.
As more Maltese households explore home cultivation, understanding light distribution and plant training could make the difference between a modest harvest and a meaningful one.
As clinical research on cannabinoids and chronic pain matures, Malta's regulated framework puts it in a unique position to translate science into policy.
As the UK's medical cannabis sector faces mounting scrutiny over weak clinical evidence, the lesson for Malta's emerging framework is clear: data collection must begin now.